A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX
This case report illustrates the therapeutic opportunities offered through identification of homologous recombination repair deficiency in pancreatic cance